Related Experiment Video
Updated: Jul 8, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Prospective validation of a model-informed precision dosing tool for vancomycin treatment in neonates
Riste Kalamees1, Hiie Soeorg1, Mari-Liis Ilmoja2
1Department of Microbiology, University of Tartu, Tartu, Estonia.
Abstract:
We recruited 48 neonates (50 vancomycin treatment episodes) in a prospective study to validate a model-informed precision dosing (MIPD) software. The initial vancomycin dose was based on a population pharmacokinetic model and adjusted every 36-48 h. Compared with a historical control group of 53 neonates (65 episodes), the achievement of a target trough concentration of 10-15 mg/L improved from 37% in the study to 62% in the MIPD group (P = 0.01), with no difference in side effects.
Related Concept Videos
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Estimation of k and VD of Aminoglycosides
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

